DHL Supply Chain Revenue Rises 12% in Q3
The logistics provider reported double-digit growth across its Americas, EMEA and Asia Pacific regions in the third quarter of 2026.
Updated on Nov. 17, 2026 in Transportation

DHL Supply Chain reported a 12% year-on-year revenue increase in the third quarter of 2026. Growth was led by the Americas at 13.1%, followed by EMEA at 11.7% and Asia Pacific at 9.9%.
Why it matters
The results point to continued demand for logistics partners as customers seek supply chain resilience, productivity and flexibility amid rising complexity. Growth was reported across life sciences, healthcare, new energy, technology, retail, consumer and automotive sectors.
DHL Supply Chain's revenue grew 12% year-on-year in Q3 2026, with the Americas up 13.1%, EMEA up 11.7% and Asia Pacific up 9.9%. The company expects 2026 customer contracts to far exceed €8bn in Total Contract Value, with the Americas contributing about 45% and EMEA about 35%.
The players
DHL Supply Chain
DHL Supply Chain is the contract logistics division of DHL Group, operating in more than 55 countries and managing more than 250 pharmaceutical logistics facilities globally.
Sanofi
Sanofi is a global pharmaceutical company whose vaccine distribution operations DHL Supply Chain has managed in France and at other sites since 2024.
The details
DHL Supply Chain, part of DHL Group, says its investments are focused on artificial intelligence, robotics, automation and acquisitions. The company is also commissioning newly built multi-user pharmaceutical warehouses, and reports roughly 90% contract renewal.
Timeline
2024: DHL Supply Chain began managing three Sanofi distribution sites.
Q3 2026: The company reported 12% year-on-year revenue growth.
2026: DHL took over Sanofi's vaccine distribution centre in Val-de-Reuil, France.
Market Landscape
The growth extends DHL's pharmaceutical logistics push that began with its 2024 management of three Sanofi distribution sites. It positions the company to capture demand in a contract logistics market where it is targeting growth about 2 percentage points above each regional market.
Companies relying on pharmaceutical and contract logistics may see continued investment in automated, multi-user warehousing as providers expand capacity. Shoppers and patients are unlikely to see direct price changes from this earnings report alone.
The takeaway
Logistics providers gaining share in pharmaceuticals and healthcare suggests that supply chain reliability, rather than price alone, is driving customer contracts. Watch how regional growth rates hold as new warehouses come online.
Further reading
For more on how logistics operators are adapting to these demands, see the Transportation section.



